Eupraxia Pharmaceuticals Announces Positive Data from Highest-Dose Cohort in the Ongoing RESOLVE Trial in Eosinophilic Esophagitis, and Plans for Expansion of EP-104GI Development Programs Biotech Investing
Lexaria Bioscience Corp. Announces Closing of $4.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Biotech Investing
ARS Pharmaceuticals Secures Up to $250 Million Loan Facility with RA Capital Management and OMERS Life Sciences to Accelerate U.S. Commercialization of neffy® Biotech Investing
Metsera Reports Positive Phase 2b Results for First- and Best-in-Class Ultra-long Acting GLP-1 RA Candidate MET-097i, Enabling Rapid Transition into Phase 3 Biotech Investing
AbbVie Breaks Ground on New North Chicago Active Pharmaceutical Ingredient Manufacturing Facility Pharmaceutical Investing
TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA Pharmaceutical Investing
Dyne Therapeutics Receives Orphan Drug Designation in Japan for DYNE-251 in Duchenne Muscular Dystrophy Biotech Investing
Medtronic Announces Closing of Public Offering of Euro1.5 Billion of Senior Notes Medical Device Investing
FDA Approves Guardant360® CDx as Companion Diagnostic for Eli Lilly and Company's Inluriyo for Treatment of ESR1-mutated Advanced Breast Cancer Genetics Investing
